ISSN 0303-5212
 

Original Research 


Level of TNF-alpha and anti-CMV in pulmonary tuberculosis patients

Zaytoon A Alkhafaji, Ali Mahmoud Shaker, Huda Hadi Al-Hasnawy, Mohammed Mohsen, Younis Abdulridha Alkhafaji, Entisar J Al-Mukhtar.

Abstract
Objective: To assess the levels of interleukins TNF-alpha in patients with pulmonary tuberculosis (pTB).
Methodology: Sixty patients with pTB who were hospitalized in the province of Hilla-Babylon provided whole blood samples from March 2019 to February 2020. The patients' ages ranged from 15 to 70 years, and there were 31 male and 29 females. TNF-alpha levels, CMV-IgG levels, and CMV-IgM levels were estimated using the ELISA method.
Results: TNF-alpha serum levels in pTB patients were substantially higher (p˂0.05) than in the healthy group (35.4) pg/ml, with an average of 68.90 pg/ml. Mean serum level of CMV-IgG was 72.44 pg/ml and was considerably higher (p˂0.05) in patients with pTB than in the healthy group (37.85 pg/ml). Mean of serum concentration of CMV-Ig M )0.153) pg/ml and was not substantially higher (p˃0.05) in individuals with pTB compared to control group (0.127) pg/ml.
Conclusion: TNF-alpha serum levels and serum level of CMV-IgG was high in pTB patients.

Key words: Pulmonary tuberculosis, TNF-α , CMV-IgG , CMV-IgM, ELISA Test.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Zaytoon A Alkhafaji
Articles by Ali Mahmoud Shaker
Articles by Huda Hadi Al-Hasnawy
Articles by Mohammed Mohsen
Articles by Younis Abdulridha Alkhafaji
Articles by Entisar J Al-Mukhtar
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Alkhafaji ZA, Shaker AM, Al-Hasnawy HH, Mohsen M, Alkhafaji YA, Al-Mukhtar EJ. Level of TNF-alpha and anti-CMV in pulmonary tuberculosis patients. RMJ. 2022; 47(4): 815-817. doi:10.5455/rmj.109630.20220826110843


Web Style

Alkhafaji ZA, Shaker AM, Al-Hasnawy HH, Mohsen M, Alkhafaji YA, Al-Mukhtar EJ. Level of TNF-alpha and anti-CMV in pulmonary tuberculosis patients. https://www.rmj.org.pk/?mno=109630 [Access: December 04, 2023]. doi:10.5455/rmj.109630.20220826110843


AMA (American Medical Association) Style

Alkhafaji ZA, Shaker AM, Al-Hasnawy HH, Mohsen M, Alkhafaji YA, Al-Mukhtar EJ. Level of TNF-alpha and anti-CMV in pulmonary tuberculosis patients. RMJ. 2022; 47(4): 815-817. doi:10.5455/rmj.109630.20220826110843



Vancouver/ICMJE Style

Alkhafaji ZA, Shaker AM, Al-Hasnawy HH, Mohsen M, Alkhafaji YA, Al-Mukhtar EJ. Level of TNF-alpha and anti-CMV in pulmonary tuberculosis patients. RMJ. (2022), [cited December 04, 2023]; 47(4): 815-817. doi:10.5455/rmj.109630.20220826110843



Harvard Style

Alkhafaji, Z. A., Shaker, . A. M., Al-Hasnawy, . H. H., Mohsen, . M., Alkhafaji, . Y. A. & Al-Mukhtar, . E. J. (2022) Level of TNF-alpha and anti-CMV in pulmonary tuberculosis patients. RMJ, 47 (4), 815-817. doi:10.5455/rmj.109630.20220826110843



Turabian Style

Alkhafaji, Zaytoon A, Ali Mahmoud Shaker, Huda Hadi Al-Hasnawy, Mohammed Mohsen, Younis Abdulridha Alkhafaji, and Entisar J Al-Mukhtar. 2022. Level of TNF-alpha and anti-CMV in pulmonary tuberculosis patients. Rawal Medical Journal, 47 (4), 815-817. doi:10.5455/rmj.109630.20220826110843



Chicago Style

Alkhafaji, Zaytoon A, Ali Mahmoud Shaker, Huda Hadi Al-Hasnawy, Mohammed Mohsen, Younis Abdulridha Alkhafaji, and Entisar J Al-Mukhtar. "Level of TNF-alpha and anti-CMV in pulmonary tuberculosis patients." Rawal Medical Journal 47 (2022), 815-817. doi:10.5455/rmj.109630.20220826110843



MLA (The Modern Language Association) Style

Alkhafaji, Zaytoon A, Ali Mahmoud Shaker, Huda Hadi Al-Hasnawy, Mohammed Mohsen, Younis Abdulridha Alkhafaji, and Entisar J Al-Mukhtar. "Level of TNF-alpha and anti-CMV in pulmonary tuberculosis patients." Rawal Medical Journal 47.4 (2022), 815-817. Print. doi:10.5455/rmj.109630.20220826110843



APA (American Psychological Association) Style

Alkhafaji, Z. A., Shaker, . A. M., Al-Hasnawy, . H. H., Mohsen, . M., Alkhafaji, . Y. A. & Al-Mukhtar, . E. J. (2022) Level of TNF-alpha and anti-CMV in pulmonary tuberculosis patients. Rawal Medical Journal, 47 (4), 815-817. doi:10.5455/rmj.109630.20220826110843